Literature DB >> 3061640

Antioestrogens in the management of hormone-dependent cancer.

S Litherland1, I M Jackson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3061640     DOI： 10.1016/0305-7372(88)90002-3

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  14 in total

Review 1.  Antineoplastic drugs in 1990. A review (Part II).

Authors:  D J Black; R B Livingston
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

Review 2.  Endocrine Therapy in the Current Management of Postmenopausal Estrogen Receptor-Positive Metastatic Breast Cancer.

Authors:  Virginia G Kaklamani; William J Gradishar
Journal:  Oncologist       Date:  2017-03-17

Review 3.  Hormone resistance, invasiveness, and metastatic potential in breast cancer.

Authors:  R Clarke; E W Thompson; F Leonessa; J Lippman; M McGarvey; T L Frandsen; N Brünner
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

Review 4.  Breast cancer (metastatic).

Authors:  Justin Stebbing; Sarah Ngan
Journal:  BMJ Clin Evid       Date:  2010-09-08

Review 5.  ER+ metastatic breast cancer: past, present, and a prescription for an apoptosis-targeted future.

Authors:  Brett Rozeboom; Nandini Dey; Pradip De
Journal:  Am J Cancer Res       Date:  2019-12-01       Impact factor: 6.166

Review 6.  Breast cancer (metastatic).

Authors:  Justin Stebbing; Sarah Slater; Maurice Slevin
Journal:  BMJ Clin Evid       Date:  2007-02-01

7.  Upregulation of AIB1, aromatase and ERα provides long-term estrogen-deprived human breast cancer cells with a mechanistic growth advantage for survival.

Authors:  Syreeta L Tilghman; Gauri Sabnis; Angela M H Brodie
Journal:  Horm Mol Biol Clin Investig       Date:  2011-01-01

8.  Comparison between novel steroid-like and conventional nonsteroidal antioestrogens in inhibiting oestradiol- and IGF-I-induced proliferation of human breast cancer-derived cells.

Authors:  A de Cupis; D Noonan; P Pirani; A Ferrera; L Clerico; R E Favoni
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

9.  Combined effects of 1,25-dihydroxyvitamin D3 and tamoxifen on the growth of MCF-7 and ZR-75-1 human breast cancer cells.

Authors:  T Vink-van Wijngaarden; H A Pols; C J Buurman; J C Birkenhäger; J P van Leeuwen
Journal:  Breast Cancer Res Treat       Date:  1994-02       Impact factor: 4.872

10.  Formestane: an effective first-line endocrine treatment for advanced breast cancer.

Authors:  N Zilembo; E Bajetta; C Noberasco; R Buzzoni; G Vicario; A Bono; A Laffranchi; G Biasi; S Dolci; E Bichisao
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.